title: DOES CISATRACURIUM AT A CLINICAL DOSE ATTENUATE THE IMMUNOSUPPRESSION AFTER SURGERY IN SMOKING PATIENTS WITH NON-SMALL CELL LUNG CANCER?
authors: Wen-qin
authors: WQ
authors: Sun
authors: Dao-bo
authors: DB
authors: Pan
authors: Ai-guo
authors: AG
authors: Zhou
authors: Hong
authors: H
authors: Mo
mesh_terms: D001279:Atracurium / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000601:surgery*; D006801:Humans; D016867:Immunocompromised Host / Q000187:drug effects*; D008175:Lung Neoplasms / Q000473:pathology / Q000601:surgery*; D009466:Neuromuscular Blocking Agents / Q000008:administration & dosage / Q000494:pharmacology; D011183:Postoperative Complications / Q000276:immunology; D012907:Smoking / Q000009:adverse effects; D013312:Stress, Physiological / Q000276:immunology
chemical_list: D009466:Neuromuscular Blocking Agents; D001279:Atracurium; C101584:cisatracurium